Views & Analysis Are European incentives speeding access in rare cancer treat... Examining the impact of support programmes for orphan treatments.
News Janssen's quarterly schizophrenia drug approved in EU Company hopes new formulation will improve patient outcomes.
Articles Brexit would be a blow for UK life sciences – regulators and... The British public is still split over Brexit – but pharma is warning of potentially serious consequences if the country votes 'Leave' on 23 June. Andrew McConaghie reports.
Views & Analysis An empowered patient means an empowered Europe Young Europeans are working together to suggest ways to manage health that will result in benefits to citizens and budgets.
Views & Analysis Obstacles to true patient centricity in Europe Campaigner and cancer patient Andrew Schorr says pharma needs to knock down the barriers to greater patient influence.
News OpenBind unveils its first AI model for drug discovery A research consortium that aims to make the UK a leader in AI-driven drug discovery, OpenBind, has hit its first major milestone.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
